| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.8M | +325.1% |
| R&D Expense | $133.8M | +49.0% |
| SG&A Expense | $35.9M | +174.4% |
| Operating Income | -$163.9M | -1151.7% |
| Interest Expense | $4.1M | +70.4% |
| Pre-tax Income | -$166.0M | -47.8% |
| Income Tax | $1.1M | — |
| Net Income | -$167.1M | -1009.3% |
| EPS (Basic) | -$1.27 | -8.5% |
| EPS (Diluted) | -$1.27 | -8.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.1M | — |
| Current Assets | $71.3M | — |
| Total Assets | $148.6M | -28.4% |
| Current Liabilities | $35.6M | +188.6% |
| Total Liabilities | $100.5M | +256.4% |
| Stockholders' Equity | $48.1M | +273.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$136.7M | -7461.9% |
| Capital Expenditures | $26.5M | +75.3% |
| Investing Cash Flow | -$26.5M | +87.2% |
| Financing Cash Flow | $200.9M | -3.8% |
| Free Cash Flow | -$163.3M | -862.9% |